133 related articles for article (PubMed ID: 22352916)
1. Review of synthesis, biological assay, and QSAR studies of HMGR inhibitors.
García I; Fall Y; Gómez G
Curr Top Med Chem; 2012; 12(8):895-919. PubMed ID: 22352916
[TBL] [Abstract][Full Text] [Related]
2. QSAR & complex network study of the HMGR inhibitors structural diversity.
García I; Diop YF; Gómez G
Curr Drug Metab; 2010 May; 11(4):307-14. PubMed ID: 20446903
[TBL] [Abstract][Full Text] [Related]
3. QSAR and complex network study of the chiral HMGR inhibitor structural diversity.
García I; Munteanu CR; Fall Y; Gómez G; Uriarte E; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(1):165-75. PubMed ID: 19026553
[TBL] [Abstract][Full Text] [Related]
4. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA).
Thilagavathi R; Kumar R; Aparna V; Sobhia ME; Gopalakrishnan B; Chakraborti AK
Bioorg Med Chem Lett; 2005 Feb; 15(4):1027-32. PubMed ID: 15686906
[TBL] [Abstract][Full Text] [Related]
6. Discovery and quantitative structure-activity relationship study of lepidopteran HMG-CoA reductase inhibitors as selective insecticides.
Zang YY; Li YM; Yin Y; Chen SS; Kai ZP
Pest Manag Sci; 2017 Sep; 73(9):1944-1952. PubMed ID: 28247468
[TBL] [Abstract][Full Text] [Related]
7. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme A reductase for cancer treatment.
Chen JB; Chern TR; Wei TT; Chen CC; Lin JH; Fang JM
J Med Chem; 2013 May; 56(9):3645-55. PubMed ID: 23570542
[TBL] [Abstract][Full Text] [Related]
9. Structural mechanism for statin inhibition of HMG-CoA reductase.
Istvan ES; Deisenhofer J
Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae.
Feng L; Zhou L; Sun Y; Gui J; Wang X; Wu P; Wan J; Ren Y; Qiu S; Wei X; Li J
Bioorg Med Chem; 2011 Jun; 19(11):3512-9. PubMed ID: 21550257
[TBL] [Abstract][Full Text] [Related]
11. Cloning, Purification, and Characterization of the Catalytic C-Terminal Domain of the Human 3-Hydroxy-3-methyl glutaryl-CoA Reductase: An Effective, Fast, and Easy Method for Testing Hypocholesterolemic Compounds.
Curcio R; Aiello D; Vozza A; Muto L; Martello E; Cappello AR; Capobianco L; Fiermonte G; Siciliano C; Napoli A; Dolce V
Mol Biotechnol; 2020 Feb; 62(2):119-131. PubMed ID: 31758489
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Sarver RW; Bills E; Bolton G; Bratton LD; Caspers NL; Dunbar JB; Harris MS; Hutchings RH; Kennedy RM; Larsen SD; Pavlovsky A; Pfefferkorn JA; Bainbridge G
J Med Chem; 2008 Jul; 51(13):3804-13. PubMed ID: 18540668
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling studies of atorvastatin analogues as HMGR inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
Wang Z; Cheng L; Kai Z; Wu F; Liu Z; Cai M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3869-76. PubMed ID: 25022881
[TBL] [Abstract][Full Text] [Related]
14. Recombinant 3-Hydroxy 3-Methyl Glutaryl-CoA Reductase from Candida glabrata (Rec-CgHMGR) Obtained by Heterologous Expression, as a Novel Therapeutic Target Model for Testing Synthetic Drugs.
Andrade-Pavón D; Cuevas-Hernández RI; Trujillo-Ferrara JG; Hernández-Rodríguez C; Ibarra JA; Villa-Tanaca L
Appl Biochem Biotechnol; 2017 Aug; 182(4):1478-1490. PubMed ID: 28138930
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of HMG-CoA Reductase: Current and Future Prospects.
Singh N; Tamariz J; Chamorro G; Medina-Franco JL
Mini Rev Med Chem; 2009 Oct; 9(11):1272-83. PubMed ID: 19929805
[TBL] [Abstract][Full Text] [Related]
16. (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential.
Ahmad S; Madsen CS; Stein PD; Janovitz E; Huang C; Ngu K; Bisaha S; Kennedy LJ; Chen BC; Zhao R; Sitkoff D; Monshizadegan H; Yin X; Ryan CS; Zhang R; Giancarli M; Bird E; Chang M; Chen X; Setters R; Search D; Zhuang S; Nguyen-Tran V; Cuff CA; Harrity T; Darienzo CJ; Li T; Reeves RA; Blanar MA; Barrish JC; Zahler R; Robl JA
J Med Chem; 2008 May; 51(9):2722-33. PubMed ID: 18412317
[TBL] [Abstract][Full Text] [Related]
17. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
Islam B; Sharma C; Adem A; Aburawi E; Ojha S
Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
[TBL] [Abstract][Full Text] [Related]
18. QSAR, docking, and CoMFA studies of GSK3 inhibitors.
García I; Fall Y; Gómez G
Curr Pharm Des; 2010; 16(24):2666-75. PubMed ID: 20642432
[TBL] [Abstract][Full Text] [Related]
19. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone.
Pak VV; Koo M; Kim MJ; Yun L; Kwon DY
Bioorg Med Chem; 2008 Feb; 16(3):1309-18. PubMed ID: 17977732
[TBL] [Abstract][Full Text] [Related]
20. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
